End-of-day quote
Taipei Exchange
03:30:00 14/05/2024 am IST
|
5-day change
|
1st Jan Change
|
137
TWD
|
-2.49%
|
|
+10.04%
|
-25.34%
|
Fiscal Period: December |
2023
|
2024
|
---|
Capitalization
1 |
25,891
|
19,329
|
Enterprise Value (EV)
1 |
25,224
|
16,110
|
P/E ratio
|
34
x
|
8.57
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
23.4
x
|
7.58
x
|
EV / Revenue
|
22.8
x
|
6.32
x
|
EV / EBITDA
|
35.7
x
|
7.06
x
|
EV / FCF
|
-
|
8.43
x
|
FCF Yield
|
-
|
11.9%
|
Price to Book
|
8.94
x
|
4.49
x
|
Nbr of stocks (in thousands)
|
1,41,094
|
1,41,088
|
Reference price
2 |
183.5
|
137.0
|
Announcement Date
|
02/04/24
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
---|
Net sales
1 |
-
|
1,106
|
2,550
|
EBITDA
1 |
-
|
705.9
|
2,282
|
EBIT
1 |
-
|
693.4
|
2,241
|
Operating Margin
|
-
|
62.68%
|
87.88%
|
Earnings before Tax (EBT)
1 |
-
|
792.5
|
2,243
|
Net income
1 |
-40.01
|
726.9
|
2,080
|
Net margin
|
-
|
65.7%
|
81.57%
|
EPS
2 |
-
|
5.400
|
15.98
|
Free Cash Flow
1 |
-
|
-
|
1,910
|
FCF margin
|
-
|
-
|
74.9%
|
FCF Conversion (EBITDA)
|
-
|
-
|
83.7%
|
FCF Conversion (Net income)
|
-
|
-
|
91.83%
|
Dividend per Share
|
-
|
-
|
-
|
Announcement Date
|
21/04/23
|
02/04/24
|
-
|
Fiscal Period: December |
2023 S1
|
2023 S2
|
---|
Net sales
1 |
566.3
|
540.1
|
EBITDA
1 |
407.3
|
298.5
|
EBIT
1 |
400.4
|
293.1
|
Operating Margin
|
70.7%
|
54.27%
|
Earnings before Tax (EBT)
1 |
481.7
|
310.8
|
Net income
1 |
494
|
232.9
|
Net margin
|
87.24%
|
43.12%
|
EPS
2 |
3.780
|
1.620
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
14/08/23
|
02/04/24
|
Fiscal Period: December |
2022
|
2023
|
2024
|
---|
Net Debt
1 |
-
|
-
|
-
|
Net Cash position
1 |
-
|
667
|
3,219
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
1,910
|
ROE (net income / shareholders' equity)
|
-
|
41.8%
|
70.9%
|
ROA (Net income/ Total Assets)
|
-
|
38%
|
69.3%
|
Assets
1 |
-
|
1,914
|
3,001
|
Book Value Per Share
2 |
-
|
20.50
|
30.50
|
Cash Flow per Share
2 |
-
|
-
|
14.70
|
Capex
1 |
-
|
-
|
2
|
Capex / Sales
|
-
|
-
|
0.08%
|
Announcement Date
|
21/04/23
|
02/04/24
|
-
|
Average target price
200
TWD Spread / Average Target +45.99% Consensus |
1st Jan change
|
Capi.
|
---|
| -25.34% | 611M | | +22.69% | 43.81B | | +24.88% | 23.01B | | +18.00% | 15.27B | | +8.91% | 13.68B | | +42.72% | 11.96B | | -6.70% | 6.98B | | -0.05% | 6.79B | | -8.87% | 5.73B | | +12.22% | 5.59B |
Generic Pharmaceuticals
|